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MinireviewHIF-1, O2, and the 3 PHDs:
How Animal Cells Signal Hypoxia
to the Nucleus
transduced to the nucleus in the form of increased HIF-1
transcriptional activity.
How Does O2 Regulate HIF-1 Expression?
HIF-1 is a heterodimer composed of a HIF-1 subunit,
which is constitutively expressed, and a HIF-1 subunit,
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the expression and transcriptional activity of which are
precisely regulated by the cellular O2 concentration
(Wang et al., 1995). Both subunits contain basic helix-Hypoxia-inducible factor 1 (HIF-1) is a global regulator
loop-helix domains that mediate dimerization and DNAof cellular and systemic O2 homeostasis in animals. A binding, as well as a second dimerization motif referredmolecular basis for O2-regulated expression of the to as the PAS domain based upon its original identifica-HIF-1 subunit has now been determined, providing
tion in the PER, ARNT, and SIM proteins. A superfamilya mechanism for changes in gene expression in re-
of PAS domain proteins has been identified, the majoritysponse to changes in cellular oxygenation.
of which are prokaryotic signal transduction molecules
involved in responding to environmental stimuli such
as light, O2 concentration, and redox state (Taylor andO2
Zhulin, 1999). This finding suggested that HIF-1 mightFor all organisms on earth, changes in O2 concentration
be directly regulated by O2 because the PAS domainsrepresent a fundamental physiologic stimulus. In ani-
of several prokaryotic proteins bind prosthetic groupsmals, this stimulus elicits both acute (rapid-onset and
such as heme. However, a bewildering collection ofshort-term) and chronic (delayed-onset and long-term)
models has been proposed over time involving signalresponses. Intracellular O2 concentrations are main-
tranduction via upstream O2 binding hemoproteins or viatained within a narrow range due to the risk of oxidative
the generation of superoxide or other reactive oxygendamage from excess O2 (hyperoxia), and of metabolic
species (ROS), either by an NAD(P)H oxidoreductasedemise from insufficient O2 (hypoxia). Whereas acute
or by the mitochondrial electron transport chain (ETC)responses often entail changes in the activity of preex-
(reviewed by Wenger, 2000). Involvement of phospho-isting proteins, chronic responses invariably involve
inositide-3-kinase, MAP kinase, and receptor tyrosinechanges in gene expression. A remarkable variety of
kinase pathways has also been implicated in the induc-molecular mechanisms that control the activity of pro-
tion of HIF-1 activity by hypoxia. In contrast, recent datakaryotic and yeast transcription factors in response to
indicating that the induction of HIF-1 in response tochanges in the environmental O2 concentration have
hypoxia is virtually instantaneous (Jewell et al., 2001)been delineated (for review, see Gilles-Gonzalez, 2001;
argued against a complex signal-transduction pathway.Poyton, 1999; Taylor and Zhulin, 1999).
The lack of consensus that has prevailed is best illus-HIF-1
trated by noting that the NADPH oxidoreductase andIn the animal kingdom, the transcriptional activator hyp-
mitochondrial ETC models were diametrically opposed,oxia-inducible factor 1 (HIF-1) functions as a global regu-
as they proposed decreased and increased ROS gener-lator of O2 homeostasis that facilitates both O2 delivery
ation, respectively, under hypoxic conditions. Theseand adaptation to O2 deprivation (reviewed in Semenza,
models were supported by experimental data derived2000). O2 delivery can be accomplished by diffusion in
primarily from the use of redox-sensitive fluorescenta roundworm (which consists of 103 cells) and HIF-1
compounds to measure ROS and from the effects ofmay have originally evolved in simple multicellular ani-
pharmacologic agents (inhibitors of NADPH oxidase ormals to regulate cellular energy metabolism (glycolysis
ETC activity) on the expression of HIF-1 and down-versus oxidative phosphorylation) according to O2 avail-
stream genes in tissue culture cells. The considerableability. In contrast, elaborate erythroid, cardiac, vascu-
limitations of these experimental approaches under-lar, and respiratory systems are required to adequately
scored the need for a genetic approach to the problemsupply O2 to adult mammals (many of which consist of of hypoxia signal transduction.
1013 cells) and HIF-1 is required for the establishment
VHLand utilization of each of these systems. The number of
Direct analysis of HIF-1 revealed that the protein is
known HIF-1 target genes continues to increase rapidly
subject to ubiquitination and proteasomal degradation
and the established roles of the encoded proteins (Fig-
under nonhypoxic conditions (Huang et al., 1998; Kallio
ure 1) provides a molecular basis for understanding how et al., 1999; Salceda and Caro, 1997), a process that is
HIF-1 controls the various developmental and physio- inhibited under hypoxic conditions (Sutter et al., 2000).
logical processes described above. Because of the criti- O2-regulated expression of HIF-1 is mediated by acal involvement of HIF-1 in development and postnatal functional domain of approximately 200 amino acids
physiology, as well as disease pathophysiology (as dis- (around residues 400–600) located C-terminal to the PAS
cussed below), a major goal for investigators in the field domain. Somatic cell genetics was utilized to demon-
has been to understand the molecular mechanisms by strate that renal carcinoma cells derived from patients
which the physiologic signal (reduced O2 availability) is with von Hippel-Lindau syndrome, which lack expres-
sion of the VHL tumor-suppressor protein, constitutively
express HIF-1 target genes as a result of constitutive1 Correspondence: gsemenza@jhmi.edu
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Figure 1. Representative HIF-1 Target Genes
and Their Roles in Oxygen Homeostasis
HIF-1-regulated genes include the 11 glyco-
lytic enzymes aldolase A, aldolase C, enolase
1, glyceraldehyde-3-phosphate dehydroge-
nase, hexokinase 1, hexokinase 2, lactate de-
hydrogenase A, phosphofructokinase L, phos-
phoglycerate kinase 1, pyruvate kinase M, and
triosephosphate isomerase. Abbreviations:
EPO, erythropoietin; HO, heme oxygenase;
IGF, insulin-like growth factor; IGFBP, IGF
binding protein; NOS, nitric oxide synthase;
PAI, plasminogen activator inhibitor; TGF,
transforming growth factor; VEGF, vascular
endothelial growth factor.
expression of HIF-1 (Maxwell et al., 1999). Downregula- strated that vhl-1 mutant worms (which lack VHL
function) constitutively express HIF-1, similar to thetion of HIF-1 activity and target gene expression under
nonhypoxic conditions can be restored by stable trans- renal carcinoma cells derived from patients with von
Hippel-Lindau syndrome. In vitro-translated worm HIF-fection of a VHL expression vector. Biochemical studies
demonstrated, first, that VHL is the recognition compo- 1did not bind to VHL unless it was incubated with worm
extract, suggesting a requirement for prolyl hydroxylasenent of an E3 ubiquitin-protein ligase that targets HIF-
1 for degradation and, second, that interaction with (PH) activity, as previously demonstrated in mammalian
cells. Mutation of a proline residue (Pro-621) in wormVHL requires the O2- and iron-dependent hydroxylation
of proline residue 564 in HIF-1 by an enzymatic activity HIF-1 eliminated interaction with VHL, similar to the
effect of mutating Pro-564 in human HIF-1, thus provid-distinct from the known procollagen prolyl hydroxylases
(Ivan et al., 2001; Jaakkola et al., 2001) (Figure 2). Thus, ing further evidence for an evolutionarily conserved
mechanism of proline hydroxylation.although these studies represented a major advance in
the field, the excitement was tempered by the lack of a To identify a putative PH, the investigators searched
the C. elegans genome database for sequences thatmolecular characterization of the putative enzyme.
PHDs might encode a member of the 2-oxoglutarate-depen-
dent oxygenase superfamily based on the presence ofIn this issue of Cell, an elegant series of experiments is
reported which utilize a genetic approach in the round- a -barrel jelly roll motif which contains the catalytic
site of these enzymes. This search criterion led to theworm C. elegans to delineate the molecular basis for
regulation of HIF-1 expression by the cellular O2 con- egl-9 gene, which encoded a protein product of pre-
viously unknown function. Like vhl-1 mutants, egl-9 mu-centration (Epstein et al., 2001). In this study, the investi-
gators identified VHL and HIF-1 homologs, and demon- tant worms constitutively expressed HIF-1. In vitro-
Figure 2. Regulation of HIF-1 Expression by Cellular O2 Concentration
O2 availability determines the rate at which HIF-1 is subject to prolyl hydroxylation by PHDs 1-3. Prolyl hydroxylation is required for the
interaction of HIF-1 with VHL which recruits elongins B and C, Cullin 2 (CUL2), and RBX1 (R) to constitute a functional E3 ubiquitin-protein
ligase complex. Ubiquitination of HIF-1 targets the protein for degradation by the 26S proteasome. Under hypoxic conditions, HIF-1 dimerizes
with HIF-1, which escapes prolyl hydroxylation, ubiquitination and degradation. The HIF-1 heterodimer binds to hypoxia response elements
containing the core recognition sequence 5-RCGTG-3 and recruits coactivator (Coact) molecules resulting in increased transcription initiation
complex (TIC) formation and mRNA synthesis that ultimately results in the production of proteins that mediate physiologic responses to
hypoxia. The battery of HIF-1 target genes that are expressed in response to hypoxia is cell-type-specific and is determined by the binding
of other transcription factors (TFs) which establish basal rates of transcription.
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translated EGL-9 could replace worm extract in stimulat- major distinguishing characteristic being that the modifi-
ing the interaction of VHL with wild-type HIF-1, but cation is O2 regulated. It should be possible to utilize
not when Pro-621 was mutated. The ability of EGL-9 to proteomic techniques to identify proteins other than
generate HIF-1 containing 4-hydroxyproline was dem- HIF-1 whose expression is increased in egl-9 mutant
onstrated directly by HPLC to establish that EGL-9 was worms.
indeed a HIF-1 PH. Clinical Relevance
Using the EGL-9 sequence, the investigators next Hypoxia plays an important role in the pathophysiology
identified three ubiquitously expressed EGL-9 homologs of ischemic cardiovascular disease, cancer, stroke, and
in mammals, designated PHD (PH domain-containing chronic lung disease, which are the most common
protein) 1, 2, and 3, each of which hydroxylates human causes of mortality in the U.S. population. There is a
HIF-1 at Pro-564. In contrast, only PHD1 and PHD2 growing body of data indicating that HIF-1 contributes
hydroxylate Pro-402, a second site of prolyl hydroxyla- to the pathogenesis of cancer and hypoxic pulmonary
tion and VHL binding identified by the same group. The hypertension while protecting against the ischemia and
proline residues that are subject to hydroxylation in both infarction (reviewed in Semenza, 2000). Whether tar-
worm and mammalian HIF-1 proteins are embedded geting HIF-1 for inhibition (in cancer and lung disease)
within the amino acid motif LXXLAP. Finally, the investi- or induction (in ischemic disorders) will be of therapeutic
gators demonstrated that the ability of in vitro-translated utility remains to be established. The delineation of the
PHD1 to modify HIF-1 (as measured by the binding of evolutionarily-conserved PHD-VHL-HIF-1 pathway has
HIF-1 to VHL) was dependent upon the ambient O2 now provided multiple targets and will hopefully lead to
concentration. Thus, whereas the PHD proteins require the discovery of pharmacologic agents that can be used
iron, oxoglutarate, and O2 as cofactors, these results for proof-of-principle experiments in animal models and
suggest that O2 is rate limiting for PH activity, a finding as a lead for the development of agents that can be
that provides the long-sought molecular basis for the used in clinical trials. Whereas such important clinical
regulation of HIF-1 expression by the cellular O2 con- applications remain to be demonstrated in the future,
centration. the work of Epstein et al. (2001) has now provided us
The multiplicity of mammalian PHDs in contrast to with a much better appreciation of how each cell in a
the single worm enzyme provides justification for the multicellular animal can sense changes in O2 concentra-
genetic approach in a model organism, as it is likely that tion and send this signal to the nucleus.
studies in mammalian cells would have been frustrated
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